financetom
Business
financetom
/
Business
/
Sezzle Insider Sold Shares Worth $2,048,840, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sezzle Insider Sold Shares Worth $2,048,840, According to a Recent SEC Filing
Jun 28, 2024 7:59 AM

10:37 AM EDT, 06/28/2024 (MT Newswires) -- Paul Martin Purcell, Former Director, on June 27, 2024, sold 23,737 shares in Sezzle ( SEZL ) for $2,048,840. Following the Form 4 filing with the SEC, Purcell has control over a total of 414,873 shares of the company, with 414,873 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1662991/000186499124000011/xslF345X03/primary_doc.xml

Price: 87.86, Change: -0.07, Percent Change: -0.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
P10 Appoints Andrew Corsi as Chief Accounting Officer
P10 Appoints Andrew Corsi as Chief Accounting Officer
Jan 7, 2025
04:16 PM EST, 01/07/2025 (MT Newswires) -- P10 (PX) said in a Tuesday filing its board appointed Andrew Corsi as chief accounting officer on Jan. 1. Corsi succeeds Amanda Coussens, who will continue to serve as chief financial officer and principal financial officer, the company said. Corsi previously served as P10's corporate controller, the company added. ...
Personalis Reports Lower Preliminary Revenue for Q4
Personalis Reports Lower Preliminary Revenue for Q4
Jan 7, 2025
04:18 PM EST, 01/07/2025 (MT Newswires) -- Personalis ( PSNL ) reported late Tuesday preliminary Q4 revenue of $16.8 million, down from $19.7 million a year earlier. Analysts polled by FactSet expected $15.5 million for the quarter ended Dec. 31. ...
Halozyme Therapeutics Insider Sold Shares Worth $500,060, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $500,060, According to a Recent SEC Filing
Jan 7, 2025
04:19 PM EST, 01/07/2025 (MT Newswires) -- Jeffrey William Henderson, Director, on January 06, 2025, sold 10,000 shares in Halozyme Therapeutics ( HALO ) for $500,060. Following the Form 4 filing with the SEC, Henderson has control over a total of 43,611 shares of the company, with 43,611 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000141588925000995/xslF345X05/form4-01072025_090159.xml ...
AAR Fiscal Q2 Adjusted Earnings, Sales Rise; Shares Climb After Hours
AAR Fiscal Q2 Adjusted Earnings, Sales Rise; Shares Climb After Hours
Jan 7, 2025
04:16 PM EST, 01/07/2025 (MT Newswires) -- AAR (AIR) reported fiscal Q2 adjusted earnings late Tuesday of $0.90 per diluted share, up from $0.81 a year earlier. Four analysts polled by FactSet expected $0.85. Sales in the three months ended Nov. 30 rose to $686.1 million from $545.4 million a year earlier. Analysts surveyed by FactSet expected $654.2 million. Shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved